Neural network analysis of lymphoma microarray data: prognosis and diagnosis near-perfect

BMC Bioinformatics

Li Song¹  Michael C O'Neill¹ 

[1]Department of Biological Sciences, University of Maryland, Baltimore County Baltimore, Maryland 21250, USA

关键词: diagnosis;    prognosis;    neural networks;    microarray data;    diffuse large B-cell lymphoma;   

Others  :  1171898
DOI  :  10.1186/1471-2105-4-13

 received in 2003-03-12, accepted in 2003-04-10,  发布年份 2003

【 摘 要 】

Background

Microarray chips are being rapidly deployed as a major tool in genomic research. To date most of the analysis of the enormous amount of information provided on these chips has relied on clustering techniques and other standard statistical procedures. These methods, particularly with regard to cancer patient prognosis, have generally been inadequate in providing the reduced gene subsets required for perfect classification.

Results

Networks trained on microarray data from DLBCL lymphoma patients have, for the first time, been able to predict the long-term survival of individual patients with 100% accuracy. Other networks were able to distinguish DLBCL lymphoma donors from other donors, including donors with other lymphomas, with 99% accuracy. Differentiating the trained network can narrow the gene profile to less than three dozen genes for each classification.

Conclusions

Here we show that artificial neural networks are a superior tool for digesting microarray data both with regard to making distinctions based on the data and with regard to providing very specific reference as to which genes were most important in making the correct distinction in each case.

【 授权许可】

   
2003 O'Neill and Song; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Alizedeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, et al.: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000, 403:503-510.
• [2]Werbos PJ: The Roots of Backpropagation. New York: John Wiley & Sons 1994.
• [3]O'Neill MC: A general procedure for locating and analyzing protein-binding sequence motifs in nucleic acids. Proc Natl Acad Sci USA 1998, 95:10710-10715.
• [4]Hastie T, Tibshirani R, Eisen MB, Alizedah A, Levy R, Staudt L, Chan WC, Botstein D, Brown P: Gene shaving as a method for identifying distinct sets of genes with similar expression patterns. Genome Biology 2000, 1:research0003. BioMed Central Full Text
• [5]Shipp MA, Ross KN, Tamayo P, Weng AP, Kutok JL, Aguiar RCT, Gaasenbeek M, Angelo M, Reich M, Pinkus GS, et al.: Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nature Medicine 2002, 1:68-74.
• [6]Alon U, Barkai N, Noterman DA, Gish K, Ybarra S, Mack D, Levine AJ: Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc Natl Acad Sci USA 1999, 96:6745-6750.
• [7]Rosenwald A, Wright G, Wing CC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Staudt LM: The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. The New England Journal of Medicine 2002, 346:1937-1947.
• [8]van't Veer LJ, Dai H, vande Vijver MJ, He YD, Hart AM, Mao M, Peterse HL, van derKooy K, Marton MJ, Witteveen AT, et al.: Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415:530-536.
• [9]Beer DG, Kardia SLR, Huang C-C, Giordano TJ, Levin AM, Misek DE, Lin L, Chen G, Gharib TG, Thomas DG, et al.: Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nature Medicine 8:816-824.
• [10]Khan J, Wei JS, Ringner M, Saal LH Ladanyi M, Westermann F, Berthold F, Schwab M, Antonescu CR, Peterson C, Meltzer PS: Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nature Medicine 2001, 7:673-679.
• [11]Dhanasekaran SM, Barrette TR, Chosh D, Shah R, Varambally S, Kurachi K, Pienta KJ, Rubin MA, Chinnalyan AM: Delineation of prognostic biomarkers in prostate cancer. Nature 2001, 412:822-826.
• [12]Perou CM, Serlie T, Elsen MB, van deRijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, et al.: Molecular portraits of human breast tumours. Nature 2000, 406:747-752.